Literature DB >> 12771606

Adrenocortical hormones in survivors and nonsurvivors of severe sepsis: diverse time course of dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol.

Christian Marx1, Sirak Petros, Stefan R Bornstein, Matthias Weise, Matthias Wendt, Mario Menschikowski, Lothar Engelmann, Gert Höffken.   

Abstract

OBJECTIVE: Activation and suppression of immune responses are crucial events during sepsis. Based on substantial new data, a complex picture of differential immune-enhancing and immunosuppressive actions of adrenocortical steroids is emerging. The adrenal androgen dehydroepiandrosterone and its precursor, dehydroepiandrosterone-sulfate, show a considerable decrease with increasing age and serve as functional antagonists to endogenous glucocorticoids. Therefore, we examined time-dependent changes in dehydroepiandrosterone, dehydroepiandrosterone-sulfate, cortisol, adrenocorticotropin, and inflammatory variables in surviving and nonsurviving patients with severe sepsis.
DESIGN: Prospective observational study in consecutive patients.
SETTING: Medical and interdisciplinary intensive care units in two university hospitals and one city hospital. PATIENTS: Thirty nonsurgical patients (25 men and 5 women) with severe sepsis (American College of Chest Physicians/Society of Critical Care Medicine criteria); 15 survivors (mean age, 54 +/- 14 yrs; Acute Physiology and Chronic Health Evaluation III score, 59 +/- 35) and 15 nonsurvivors (mean age, 63 +/- 15 yrs; Acute Physiology and Chronic Health Evaluation III score, 67 +/- 24) were included. Hormones were compared individually and between survivors/nonsurvivors by sequential blood drawings from early sepsis till time of recovery/death.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: During early sepsis, cortisol (nmol/L) was not significantly higher in survivors than nonsurvivors (750 +/- 121 vs. 454 +/- 92, p <.08) and decreased in survivors (p <.01) during late sepsis. During early sepsis, dehydroepiandrosterone-sulfate (percentage of age-matched normal levels) was higher in survivors than nonsurvivors (85 +/- 19 vs. 22 +/- 7, p <.01). Dehydroepiandrosterone-sulfate decreased in survivors (p =.0001) but remained low in nonsurvivors during late sepsis. Dehydroepiandrosterone (percentage of age-matched normal levels) was not significantly elevated in survivors compared to nonsurvivors during early sepsis (282 +/- 42 vs. 214 +/- 63, p <.08). Dehydroepiandrosterone decreased in survivors (p <.01) but not in nonsurvivors during late sepsis. Linear regression for dehydroepiandrosterone levels showed a reconstitution of age dependence only in survivors during recovery. Adrenocorticotropin levels did not change. The dehydroepiandrosterone-sulfate/cortisol ratio decreased significantly in both survivors and nonsurvivors, whereas dehydroepiandrosterone/cortisol ratio only decreased in survivors during course of sepsis.
CONCLUSIONS: During sepsis, adrenal androgens and glucocorticoids show a diverse time-dependent course in survivors and nonsurvivors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771606     DOI: 10.1097/01.CCM.0000063282.83188.3D

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  19 in total

Review 1.  Is there a role for dehydroepiandrosterone replacement in the intensive care population?

Authors:  Ketan K Dhatariya
Journal:  Intensive Care Med       Date:  2003-09-03       Impact factor: 17.440

2.  Proven infection-related sepsis induces a differential stress response early after ICU admission.

Authors:  Olivier Lesur; Jean-Francois Roussy; Frederic Chagnon; Nicole Gallo-Payet; Robert Dumaine; Philippe Sarret; Ahmed Chraibi; Lucie Chouinard; Bruno Hogue
Journal:  Crit Care       Date:  2010-07-09       Impact factor: 9.097

3.  Are alterations of lymphocyte subpopulations in polymicrobial sepsis and DHEA treatment mediated by the tumour necrosis factor (TNF)-alpha receptor (TNF-RI)? A study in TNF-RI (TNF-RI(-/-)) knock-out rodents.

Authors:  F Hildebrand; H-C Pape; P Harwood; T Wittwer; C Krettek; M van Griensven
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

4.  Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.

Authors:  C G Ziegler; J W Brown; A V Schally; A Erler; L Gebauer; A Treszl; L Young; L M Fishman; J B Engel; H S Willenberg; S Petersenn; G Eisenhofer; M Ehrhart-Bornstein; S R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-27       Impact factor: 11.205

Review 5.  Systemic illness.

Authors:  Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio; Ettore C degli Uberti
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

6.  A prospective study on adrenal cortex responses and outcome prediction in acute critical illness: results from a large cohort of 203 mixed ICU patients.

Authors:  Ioanna Dimopoulou; Konstantinos Stamoulis; Ioannis Ilias; Marinella Tzanela; Panagiotis Lyberopoulos; Stylianos Orfanos; Apostolos Armaganidis; Maria Theodorakopoulou; Stylianos Tsagarakis
Journal:  Intensive Care Med       Date:  2007-08-08       Impact factor: 17.440

7.  Relationship between thyroid function and ICU mortality: a prospective observation study.

Authors:  Feilong Wang; Wenzhi Pan; Hairong Wang; Shuyun Wang; Shuming Pan; Junbo Ge
Journal:  Crit Care       Date:  2012-01-19       Impact factor: 9.097

8.  Prognostic value of dehydroepiandrosterone-sulfate and other parameters of adrenal function in acute ischemic stroke.

Authors:  Claudine A Blum; Cornelia Mueller; Philipp Schuetz; Felix Fluri; Michael Trummler; Beat Mueller; Mira Katan; Mirjam Christ-Crain
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

9.  Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate.

Authors:  Nienke Molenaar; Ronald M Bijkerk; Albertus Beishuizen; Christel M Hempen; Margriet F C de Jong; Istvan Vermes; Gertjan van der Sluijs Veer; Armand R J Girbes; A B Johan Groeneveld
Journal:  Crit Care       Date:  2012-07-10       Impact factor: 9.097

10.  Hormonal status in protracted critical illness and in-hospital mortality.

Authors:  Tarek Sharshar; Sylvie Bastuji-Garin; Andrea Polito; Bernard De Jonghe; Robert D Stevens; Virginie Maxime; Pablo Rodriguez; Charles Cerf; Hervé Outin; Philippe Touraine; Kathleen Laborde
Journal:  Crit Care       Date:  2011-02-03       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.